Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Veith, Sushil Gupta, E. Ascer, S. White-Flores, R. Samson, L. Scher, J. Towne, V. Bernhard, P. Bonier, W. Flinn, P. Astelford, James Yao, J. Bergan (1986)
Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions.Journal of vascular surgery, 3 1
D. Rosenthal, K. Levine, P. Stanton, P. Lamis (1983)
Femoropopliteal bypass: the preferred site for distal anastomosis.Surgery, 93 1 Pt 1
D. Brewster, A. LaSalle, J. Robison, E. Strayhorn, R. Darling (1983)
Factors affecting patency of femoropopliteal bypass grafts.Surgery, gynecology & obstetrics, 157 5
Mahir MS Dormandy JA (1986)
Vascular Surgery: Issues in Current Practice
N. Breslow (1970)
A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 57
Szilagyi De, J. Hageman, Smith Rf, Joseph Elliott, F. Brown, P. Dietz (1979)
Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness.Surgery, 86 6
M. Criqui, R. Langer, A. Fronek, H. Feigelson, M. Klauber, T. McCann, D. Browner (1992)
Mortality over a period of 10 years in patients with peripheral arterial disease.The New England journal of medicine, 326 6
H. Tilanus, H. Obertop, H. Urk (1985)
Saphenous Vein or PTFE for Femoropopliteal Bypass: A Prospective Randomized TrialAnnals of Surgery, 202
G. Kretschmer, M. Schemper, H. Ehringer, E. Wenzl, P. Polterauer, L. Marçosi, E. Minar (1988)
INFLUENCE OF POSTOPERATIVE ANTICOAGULANT TREATMENT ON PATIENT SURVIVAL AFTER FEMOROPOPLITEAL VEIN BYPASS SURGERYThe Lancet, 331
E. Kaplan, P. Meier (1958)
Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 53
Cornfield J (1978)
Randomization by group: a formal analysisAm J Epidemiol, 108
Obertop H Tilanus HW (1985)
Saphenous vein or PTFE for femoropopliteal bypassAnn Surg, 202
Pål Smith, H. Arnesen, I. Holme (1990)
The effect of warfarin on mortality and reinfarction after myocardial infarction.The New England journal of medicine, 323 3
D. Brewster, A. LaSalle, J. Robison, E. Strayhorn, R. Darling (1983)
Femoropopliteal graft failures. Clinical consequences and success of secondary reconstructions.Archives of surgery, 118 9
Deweese Ja, Roberts Cg (1977)
Autogenous venous grafts ten years later.Surgery, 82
W. Quiñones-Baldrich, V. Martín‐Paredero, J. Baker, R. Busuttil, H. Machleder, W. Moore (1984)
Polytetrafluoroethylene grafts as the first-choice arterial substitute in femoropopliteal revascularization.Archives of surgery, 119 11
F. Veith, S. Gupta, V. Daly (1980)
Management of early and late thrombosis of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts: favorable prognosis with appropriate reoperation.Surgery, 87 5
Cochran WG (1977)
Sampling Techniques
R. Rosen, W. Johnson, H. Bush, S. Cho, E. O'Hara, D. Nabseth (1986)
Staged infrainguinal reascularization: Initial prosthetic above-knee bypass followed by a distal vein bypass for recurrent ischemiaAmerican Journal of Surgery, 152
S. Simone, B. Dubner, A. Safi, P. delGuercio, M. Shah, L. Zagorin, F. Reichle (1981)
Comparative review of early and intermediate patency rates of polytetrafluoroethylene and autogenous saphenous vein grafts for lower extremity ischemia.Surgery, 90 6
J. Cornfield (1978)
SYMPOSIUM ON CHD PREVENTION TRIALS: DESIGN ISSUES IN TESTING LIFE STYLE INTERVENTIONRANDOMIZATION BY GROUP: A FORMAL ANALYSISAmerican Journal of Epidemiology, 108
John Bergan, John Bergan, John Bergan, Frank Veith, Frank Veith, Frank Veith, Victor Bernhard, Victor Bernhard, Victor Bernhard, James Yao, James Yao, James Yao, W. Flinn, W. Flinn, W. Flinn, Sushil Gupta, Sushil Gupta, Sushil Gupta, L. Scher, Russell Samson, Russell Samson, Russell Samson, Towne Jb, Towne Jb, Towne Jb (1982)
Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction.Surgery, 92 6
Thompson R Yashar JJ (1981)
Dacron vs vein for femoropopliteal arterial bypassArch Surg, 116
N. Mantel (1966)
Evaluation of survival data and two new rank order statistics arising in its consideration.Cancer chemotherapy reports, 50 3
D. Cox (1972)
Regression Models and Life-TablesJournal of the royal statistical society series b-methodological, 34
Kim M Fontaine R (1954)
Die chirurgische Behandlung der peripheren Durchblutungsst�rungenHelv Chir Acta, 21
Cox DR (1972)
Regression models and life tablesJR Stat Soc, B34
J. Yashar, R. Thompson, R. Burnard, A. Weyman, J. Yashar, R. Hopkins (1981)
Dacron vs vein for femoropopliteal arterial bypass. Should the saphenous vein be spared?Archives of surgery, 116 8
Abstract Objective: The choice of material for above-knee femoropopliteal bypass grafting is a matter of continuing controversy for various reasons. The most important argument in favor of alloplastic grafts is to preserve the autologous saphenous vein for a below-knee bypass, which might become indicated at a later date. Design: A consecutive series of above-knee reconstructions were analyzed with regard to long-term behavior. Early graft occlusions were not included, and the median follow-up was 83 months. Setting: A university hospital with a particular interest in vascular surgery. Patients and Methods: Four hundred forty-two patients received either autologous saphenous vein (n=310) or alloplastic graft (n=132) material, and were analyzed in a univariate (Kaplan-Meier) and multivariate (Cox) manner. Main Outcome Measures: Analysis as to whether alloplastic graft material provides equal or less favorable results as compared with autologous saphenous vein material, in terms of primary and secondary patency, secondary below-knee bypass grafting, limb salvage, and survival. Results: Although univariate analysis demonstrated a significantly better primary patency rate for autologous saphenous vein material, multivariate analysis did not show any effect of the material in terms of patency, limb salvage, and survival. The frequency of secondary belowknee repair was 7% (31 patients); 56% were performed in the first 2 years postoperatively. This amounted to an estimated probability of 4.4% and 12.3% at 18 years, respectively. Conclusion: The small probability of secondary below-knee repair in our series does not support the policy to use alloplastic grafts routinely for a primary above-knee bypass, to spare the saphenous vein. Therefore, patients should be offered the best material for the first operation even at the above-knee level.(Arch Surg. 1994;129:297-302) References 1. De Weese JA, Rob CG. Autogenous venous grafts ten years later . Surgery . 1977;82:775-784. 2. Brewster DC, LaSalle AJ, Robison JG, Robinson JG, Strayhorn EC, Darling RC. Factors affecting patency of femoropopliteal bypass grafts . Surg Gynecol Obstet . 1983:157:437-442. 3. Bergan JJ, Veith FJ, Bernhard VM, et al. Randomization of autogenous vein and polytetrafuoroethylene grafts in femoro-distal reconstruction . Surgery . 1982; 92:921-930. 4. Tilanus HW, Obertop H, Van Urk H. Saphenous vein or PTFE for femoropopliteal bypass . Ann Surg . 1985;202:780-782.Crossref 5. Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparsion of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstruction . J Vasc Surg . 1986;3:104-114.Crossref 6. Rosenthal D, Levine K, Stanton PE, Lamis PA. Femoropopliteal bypass: the preferred site for distal anastomosis . Surgery . 1983;93:1-4. 7. Quinones-Baldrich WJ, Martin-Paredero V, Baker JD, Busuttil RW, Machleder HI, Moore WS. Polytetrafluoroethylene grafts as the first-choice arterial substitute in femoropopliteal revascularization . Arch Surg . 1984:119:1238-1243.Crossref 8. Rosen RC, Johnson WC, Bush HL, Cho SI, O'Hara ET, Nabseth DC. Staged infrainguinal revascularization: initial prosthetic above-knee bypass followed by a distal vein bypass for recurrent ischemia . Am J Surg . 1986;152:224-230.Crossref 9. Cornfield J. Randomization by group: a formal analysis . Am J Epidemiol . 1978; 108:100-102. 10. Cochran WG. Sampling Techniques . 3rd ed. New York, NY: John Wiley & Sons Inc; 1977. 11. Fontaine R, Kim M, Kieny R. Die chirurgische Behandlung der peripheren Durchblutungsstörungen . Helv Chir Acta . 1954;21:499-533. 12. Cox DR. Regression models and life tables . JR Stat Soc . 1972;B34:187-220. 13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations . J Am Stat Assoc . 1958;53:457-481.Crossref 14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration . Cancer Chemother Rep . 1966;50:163-170. 15. Breslow N. A generalized Kruskal-Wallis test for comparing k-samples subject to unequal patterns of censorship . Biometrika . 1970;57:579-594.Crossref 16. Yashar JJ, Thompson R, Burnard RJ, Weyman AK, Yashar J, Hopkins RW. Dacron vs vein for femoropopliteal arterial bypass . Arch Surg . 1981;116:1037-1040.Crossref 17. Simone ST, Dubner B, Safi AR, et al. Comparative review of early and intermediate patency rates of polytetrafluoroethylene and autogenous saphenous vein grafts for lower extremity ischemia . Surgery . 1981;90:991-999. 18. Veith FJ, Gupta SK, Daly V. Management of early and late thrombosis of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts: favorable prognosis with appropriate reoperation . Surgery . 1980;87:581-587. 19. Brewster DC, LaSalle AJ, Robinson JG, Strayhorn EC, Darling RC. Femoropopliteal graft failures: clinical consequences and success of secondary reconstructions . Arch Surg . 1983;118:1043-1047.Crossref 20. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease . N Engl J Med . 1992;326:381-386.Crossref 21. Kretschmer G, Wenzl E, Schemper M, et al. Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery . Lancet . 1988;1:797-799.Crossref 22. Smith P, Arnesen H, Holme J. The effect of warfarin on mortality and rein-farction after myocardial infarction . N Engl J Med . 1990;323:147-152.Crossref 23. Dormandy JA, Mahir MS. The natural history of peripheral atheromatous disease of the legs . In: Greenhalgh RM, Jamieson CW, Nicolaides AN, eds. Vascular Surgery: Issues in Current Practice . New York, NY: Grune & Stratton; 1986:3-18. 24. Szilagyi DE, Hageman JH, Smith RF, Elliott JP, Brown F, Dietz P. Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness . Surgery . 1979;86:836-851.
Archives of Surgery – American Medical Association
Published: Mar 1, 1994
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.